Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma

被引：0
|
作者：
Yudai Ishiyama
Tsunenori Kondo
Hidekazu Tachibana
Hiroki Ishihara
Hironori Fukuda
Kazuhiko Yoshida
Toshio Takagi
Junpei Iizuka
Kazunari Tanabe
机构：
[1] Tokyo Women’s Medical University Medical Center East,Department of Urology
[2] Tokyo Women’s Medical University,Department of Urology
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Metastatic kidney cancer; Biomarkers; Immunotherapy; Immune-checkpoint inhibitor; Prognosticator;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：552 / 561
页数：9
相关论文
共 50 条
  • [41] Outcomes in Brain Metastatic Renal Cell Carcinoma Treated with Stereotactic Radiation Therapy and Nivolumab
    Mohammadi, H.
    Tolpin, A. B.
    Peacock, J.
    Oliver, D. E.
    Sim, A. J.
    Palm, R.
    Ahmed, K. A.
    Liu, J. K.
    Tran, N.
    Etame, A. B.
    Robinson, T. J.
    Yu, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E82 - E82
  • [42] Treatment outcomes of molecular targeted therapy following nivolumab in metastatic renal cell carcinoma
    Bando, Yukari
    Furukawa, Junya
    Terakawa, Tomoaki
    Harada, Kenichi
    Hinata, Nobuyuki
    Nakano, Yuzo
    Fujisawa, Masato
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (08) : 1313 - 1318
  • [43] GENOMIC BIOMARKERS OF RESPONSE TO NIVOLUMAB/IPILIMUMAB AND NIVOLUMAB MONOTHERAPY IN 108 PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    DiNatale, Renzo
    Lee, Chung-Han
    Chowell, Diego
    Makarov, Vladimir
    Redzematovic, Almedina
    Murray, Samuel
    Carlo, Maria
    Voss, Martin
    Coleman, Jonathan
    Russo, Paul
    Motzer, Robert
    Chan, Timothy
    Hakimi, Ari
    JOURNAL OF UROLOGY, 2019, 201 (04): : E346 - E346
  • [44] Rapid development of an atypical meningioma during Nivolumab therapy for metastatic renal cell carcinoma
    Abele, N.
    Luchtmann, M.
    Donitza, A.
    Janitzky, A.
    Sandalcioglu, I. E.
    Skalej, M.
    Schostak, M.
    Reifenberger, G.
    Mawrin, C.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2020, 195
  • [45] Predictive impact of an early change in serum C-reactive protein levels in nivolumab therapy for metastatic renal cell carcinoma
    Ishihara, Hiroki
    Takagi, Toshio
    Kondo, Tsunenori
    Fukuda, Hironori
    Tachibana, Hidekazu
    Yoshida, Kazuhiko
    Iizuka, Junpei
    Okumi, Masayoshi
    Ishida, Hideki
    Tanabe, Kazunari
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (05) : 526 - 532
  • [46] Prognostic and predictive values of carbonic anhydrase IX (CAIX) and pathologic features in patients with metastatic clear cell renal cell carcinoma receiving targeted therapy
    Choueiri, T. K.
    Regan, M.
    Oh, W.
    Clement, J.
    Amato, A.
    McDermott, D.
    Cho, D.
    Atkins, M.
    Signoretti, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] PREDICTIVE IMPACT OF AN EARLY CHANGE IN SERUM C-REACTIVE PROTEIN LEVELS IN NIVOLUMAB THERAPY FOR METASTATIC RENAL CELL CARCINOMA
    Ishihara, Hiroki
    Takagi, Toshio
    Kondo, Tsunenori
    Fukuda, Hironori
    Tachibana, Hidekazu
    Yoshida, Kazuhiko
    Iizuka, Junpei
    Okumi, Masayoshi
    Ishida, Hideki
    Tanabe, Kazunari
    JOURNAL OF UROLOGY, 2020, 203 : E194 - E194
  • [48] Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
    Yoshino, Maki
    Ishihara, Hiroki
    Nemoto, Yuki
    Nakamura, Kazutaka
    Nishimura, Koichi
    Tachibana, Hidekazu
    Fukuda, Hironori
    Toki, Daisuke
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Tanabe, Kazunari
    Kondo, Tsunenori
    Takagi, Toshio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (10) : 1208 - 1214
  • [49] ROLE OF INTERFERONS IN THE THERAPY OF METASTATIC RENAL-CELL CARCINOMA
    QUESADA, JR
    UROLOGY, 1989, 34 (04) : 80 - 83
  • [50] Subcutaneous nivolumab versus intravenous nivolumab in patients with previously treated, advanced, or metastatic clear cell renal cell carcinoma
    Chacon, Matias Rodrigo
    Cutuli, Hernan J.
    Bracarda, Sergio
    Maruzzo, Marco
    Bourlon, Maria Teresa
    Jacobs, Carmel
    Perez-Valderrama, Begona
    Magri, Ignacio
    Richardet, Martin
    Centkowski, Piotr
    Fu, Simon Yuen Fai
    Gurman, Pablo
    Konduri, Srivani
    Yu, Zhuoxin
    Vezina, Heather
    George, Saby
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345